U. Schlotzer-schrehardt et al., Latent TGF-beta 1 binding protein (LTBP-1): a new marker for intra- and extraocular PEX deposits, KLIN MONATS, 216(6), 2000, pp. 412-419
Background: Pseudoexfoliation (PEX) syndrome is a generalized process of th
e extracellular matrix characterized by the accumulation of an abnormal pat
hognomonic material in various intraocular and extraocular tissues. Whereas
the intraocular manifestations can be directly diagnosed by biomicroscopic
observations, the extraocular manifestations can presently only be diagnos
ed by electron microscopic methodology. in order to better evaluate the dis
tribution and precise localization of PEX deposits in the various organ sys
tems, we searched for a relatively specific immunohistochemical marker for
PEX material on the light microscopic level.
Material and Methods: Eyes and tissue specimens of various organ systems (s
kin, heart, lungs, liver, kidney abdominal aorta, cerebral artery, plexus c
horoideus, meninges) obtained from 4 organ donors with ocular PEX syndrome
and age-matched control tissues were investigated by electron microscopy an
d immunohistochemistry using antibodies against various elastic microfibril
lar components.
Results: Out of a panel of antibodies tested, the immunolabeling of both in
tra- and extraocular PEX deposits with antibodies against. latent TGF-beta
1 binding protein (LTBP-1) was particularly prominent. In addition to the k
nown intraocular sites of PEX material accumulations, focal plaque-like LIB
P-1 positive deposits could be observed in the conjunctival stroma, optic n
erve meninges, skin, heart muscle. lungs, kidney as well as in the adventit
ia of the aorta and cerebral artery from donors with PEX syndrome; such pla
que-like deposits positive for LTBP-1 were not present in the control tissu
es. Transmission electron microscopy confirmed the presence of typical fibr
illar PEX aggregates in the respective tissues.
Conclusions: Antibodies against LTBP-1 provide a new and relatively specifi
c marker for PEX deposits both in intraocular and extraocular locations. Sy
stematic screening of PEX accumulations in a larger number of extraocular t
issue specimens obtained from PEX patients may help to elucidate the functi
onal implications and consequences of the systemic manifestations.